New patented histone deacetylase inhibitors. - Wikidata - awgldk - TriplyDB

New patented histone deacetylase inhibitors.

New patented histone deacetylase inhibitors.

http://www.wikidata.org/entity/Q37638742

about

Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions.The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.A bioluminogenic HDAC activity assay: validation and screening.Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.Butyrate histone deacetylase inhibitors.Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed.Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming.Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives.Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer.Current trends in the development of histone deacetylase inhibitors: a review of recent patent applications.Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC.Ligand release mechanisms and channels in histone deacetylases.Targeting transcription factor lysine acetylation in inflammatory airway diseases

P2860

Q30684975-1B5ACBAF-9226-47FC-B763-F61CEECDE5C7 Q33705588-11BBEEA8-F55C-4245-97FC-9F3540B5C5EA Q33829390-359A363E-A463-4357-B94A-CF7C4478E9F6 Q33989826-8082EF19-79D8-45D0-8A5E-D92BE5F7E24E Q35476003-2038CC58-0FFA-4F62-9E72-496A8FD193A9 Q36574546-121196DC-FB67-4590-80FA-32CB7AE9DF2C Q37993589-3566CD20-5111-495B-89A8-58B166E955EA Q38006956-5826F252-3C62-4156-B064-6823E5FD28BD Q38031633-88F3CA43-B321-448C-9F4D-8895100C2D93 Q38155850-6782BC89-DEA9-4DF9-BB65-ED3B6FA55FF1 Q38162900-EE078AAE-3013-4FBB-BB79-194D5F28D88F Q38822524-4D0142B2-469F-4375-A767-2D56989D8550 Q38878715-1207C316-2D1C-45EA-B4C9-D4F714AD0FEB Q45943210-98633BD8-AFF5-44CC-8997-4428076DFCAB Q57712790-D2CB902F-7BEA-4971-B1E5-E75118458453

P2860

New patented histone deacetylase inhibitors.

http://www.wikidata.org/entity/Q37638742

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New patented histone deacetylase inhibitors.

@en

New patented histone deacetylase inhibitors.

@nl

type

label

New patented histone deacetylase inhibitors.

@en

New patented histone deacetylase inhibitors.

@nl

prefLabel

New patented histone deacetylase inhibitors.

@en

New patented histone deacetylase inhibitors.

@nl

P1433

Q37638742-6125C904-D3B7-4A7D-B149-D900200486F2

P1476

Q37638742-479BD487-A6CF-47F3-B270-044E05F5AEDB

P2093

Q37638742-3415C681-E180-4E17-A7DC-A2A71C39E8DB

P2860

Q37638742-05E78AF5-D5F4-4758-B317-77775D730450

Q37638742-07B29A97-F8C3-464D-8C00-6C0CE3328382

Q37638742-1854258F-C41E-4D67-BC04-2C08138DEF5B

Q37638742-1B778F14-1E97-4745-9C15-85B341D3B1E2

Q37638742-2220EBA3-7034-4D60-8BAB-D501290E6D8E

Q37638742-31EE2F26-D298-4486-A634-942C055FA0EE

Q37638742-3479A22D-7F53-4251-B8E4-B716177C4F16

Q37638742-3D414D06-17C0-42E9-9B1D-BE1D56E2014D

Q37638742-41EFDC87-D0AC-4DBA-AD12-3913A7D2AE9C

Q37638742-48C424D7-F0C4-4C95-B9CF-2F62F0514DBE

P304

Q37638742-51EF33FB-DA78-461B-9016-B253452F3DAF

P31

Q37638742-85E8674B-935F-4E55-A316-8369B07FD784

P356

Q37638742-800B5CC9-D7E5-4F45-BE7F-9D7BB3BBF6AE

P407

Q37638742-899B0353-172E-4657-BC46-75D71CC229DB

P433

Q37638742-6EB08857-68E9-412D-9F66-08877C826285

P478

Q37638742-668F2D11-F29B-4167-A4C0-EE3B2C8A8693

P50

Q37638742-77B871B1-F82A-4BCB-A6C7-508D6A50AD5E

P577

Q37638742-D93A2783-8873-4B31-93B8-3188DD5009BD

P698

Q37638742-1B9CFD0C-0E49-4E13-B153-B46FCE583B4D

P921

Q37638742-AE1C6674-C9F8-436E-862A-B62C76139A37

P356

13543770903393789

P1433

Expert Opinion on Therapeutic Patents

P1476

New patented histone deacetylase inhibitors.

@en

P2093

Brian W Dymock

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylases (HDACs): characterization of the classical HDAC family

Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor

Histone acetylation in chromatin structure and transcription

Histone acetylation and transcriptional regulatory mechanisms

Sirtuins in mammals: insights into their biological function

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas.

The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.

Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin.

The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo

P304

1727-1757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543770903393789

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19939190

http://www.w3.org/2001/XMLSchema#string

P921